Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Exelixis, Inc. v. MSN Laboratories Private Limited et al
Case Number:
1:19-cv-02017
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
-
January 19, 2023
Exelixis Notches Win Against MSN In Cancer Drug Patent Trial
A Delaware federal judge on Thursday rejected MSN Laboratories' validity challenge to a patent on Exelixis Inc.'s blockbuster cancer drug Cabometyx, potentially keeping MSN's planned generic version off the market until 2026, while clearing the company of infringing a second patent.
-
May 12, 2022
IP Forecast: 9th Circ. To Hear A Tale Of Two Punchbowls
The operator of a newsletter called Punchbowl News that was started by former Politico reporters will head to the Ninth Circuit next week to defend its trademark win against a similarly named online invitations business. Here's a look at that case — plus all the other major intellectual property matters facing the courts in the coming week.